SB 2422 | Relating to investigations and disciplinary or punitive action by the Texas Medical Board regarding certain treatments or practices regarding COVID-19 and to the required expungement of certain records. | Perch
Texas Senate · 89th Legislature, Regular Session
SB 2422 Relating to investigations and disciplinary or punitive action by the Texas Medical Board regarding certain treatments or practices regarding COVID-19 and to the required expungement of certain records.
Sponsors
Who Authored It
Members who authored, joint-authored, or co-sponsored this bill.
By: Hall, et al.
S.B. No. 2422
A BILL TO BE ENTITLED
AN ACT
relating to investigations and disciplinary or punitive action by
the Texas Medical Board regarding certain treatments or practices
regarding COVID-19 and to the required expungement of certain
records.
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
SECTION 1. Subchapter A, Chapter 153, Occupations Code, is
amended by adding Section 153.017 to read as follows:
Show the full textCollapse the text
Explore
Related Data
Statewide figures for the subjects tagged on this bill, to explore on the Data map. They describe Texas — not this bill or its effects.
05/08/2025 H Referred to Public Health: May 8 2025 11:58PM
Change log (28 actions)
Mar 13, 2025Received by the Secretary of the Senate
Mar 13, 2025Filed
Mar 25, 2025Read first time
Mar 25, 2025Referred to Health & Human Services
Apr 1, 2025Scheduled for public hearing on . . .
Apr 1, 2025Considered in public hearing
Apr 1, 2025Testimony taken in committee
Apr 1, 2025Left pending in committee
Apr 7, 2025Co-author authorized
Apr 24, 2025Considered in public hearing
Apr 24, 2025Vote taken in committee
Apr 28, 2025Reported favorably as substituted
Apr 28, 2025
Sec. 153.017. LIMITATION ON INVESTIGATIVE AND DISCIPLINARY
AUTHORITY. Notwithstanding any other law, the board may not
investigate or take disciplinary or other punitive action against a
person regulated by the board for:
(1) prescribing or advocating for the use of
ivermectin, hydroxychloroquine, or budesonide in the prevention or
treatment of COVID-19;
(2) making statements regarding the efficacy of masks
in preventing the transmission of COVID-19; or
(3) failing to wear or require others to wear masks
intended to prevent the transmission of COVID-19 in connection with
the person's practice, other than in areas where it was customary to
wear masks before the COVID-19 pandemic.
SECTION 2. Notwithstanding any other law and not later than
December 1, 2025, the Texas Medical Board shall:
(1) review its records and expunge any record created
on or after January 1, 2020, related to the investigation of or
disciplinary or other punitive action taken against a person
regulated by the board if the record contains any of the following
words:
(A) budesonide;
(B) hydroxychloroquine;
(C) ivermectin; or
(D) mask; and
(2) in connection with each record expunged under
Subdivision (1), vacate any disciplinary action imposed and rescind
any other punitive action taken by the board.
SECTION 3. This Act takes effect immediately if it receives
a vote of two-thirds of all the members elected to each house, as
provided by Section 39, Article III, Texas Constitution. If this
Act does not receive the vote necessary for immediate effect, this
Act takes effect September 1, 2025.
Source·Texas Legislative Council (capitol.texas.gov)·official bill text (capitol.texas.gov)
Source·LegiScan (CC BY 4.0)·subject tags
Committee report printed and distributed
Apr 30, 2025Placed on intent calendar
May 5, 2025Co-author authorized
May 5, 2025Rules suspended-Regular order of business
May 5, 2025Record vote
May 5, 2025Read 2nd time & passed to engrossment
May 5, 2025Record vote
May 6, 2025Rules suspended-Regular order of business
May 6, 2025Record vote
May 6, 2025Read 3rd time
May 6, 2025Passed
May 6, 2025Record vote
May 6, 2025Reported
May 7, 2025Received from the Senate
May 8, 2025Read first time
May 8, 2025Referred to Public Health
Source·Texas Legislative Council (capitol.texas.gov)·89R